Regis CEO Matthew Doctor stepping down; Jim Lain appointed interim CEO, positive for Regis Corp.

From Nasdaq: 2025-06-23 07:50:00

Regis Corp. announced that CEO Matthew Doctor will step down on June 30, with Jim Lain serving as interim CEO. Doctor will support the transition until September 1. Lain, with 30 years of experience, will work with the executive team and Board to continue key plans. The Board has formed a Succession Planning Committee and hired a search firm for the next CEO. Positive early results for Q4 of fiscal 2025 show same-store sales up 3.0% for Supercuts and 1.3% overall compared to last year. Operating expenses are in line with the previous quarter. Regis Corp. is trading higher at $456.20 on the Nasdaq.



Read more at Nasdaq: Regis CEO Matthew Doctor To Step Down, Appoints Jim Lain As Interim CEO